Personalized Drug Therapy: Innovative Concept Guided With Proteoformics
Molecular & Cellular Proteomics · 2024-03 · 23 (3) · 100737
DOI: 10.1016/j.mcpro.2024.100737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2024-03. Verfasst von Junwen Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Science and Technology Innovation Center, Shandong Provincial Key Medical and Health Laboratory of Ovarian Cancer Multiomics, & Shandong Key …. Hauptthemen laut MEDLINE: Artificial Intelligence, Proteomics. Die Arbeit wurde bisher 125-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong First Medical University, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Science and Technology Innovation Center, Shandong Provincial Key Medical and Health Laboratory of Ovarian Cancer Multiomics, & Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institu…
Förderung
- Shandong First Medical University
- Natural Science Foundation of Shandong Province
Zitieren
APA
Su, J., Yang, L., Sun, Z., & Zhan, X. (2024). Personalized Drug Therapy: Innovative Concept Guided With Proteoformics. Molecular & Cellular Proteomics, 23(3), 100737. https://doi.org/10.1016/j.mcpro.2024.100737
Vancouver
Su J, Yang L, Sun Z, Zhan X. Personalized Drug Therapy: Innovative Concept Guided With Proteoformics. Molecular & Cellular Proteomics. 2024;23(3):100737. doi:10.1016/j.mcpro.2024.100737
BibTeX
@article{Su2024,
author = {Su, Junwen and Yang, Lamei and Sun, Ziran and Zhan, Xianquan},
title = {Personalized Drug Therapy: Innovative Concept Guided With Proteoformics},
journal = {Molecular & Cellular Proteomics},
year = {2024},
volume = {23},
number = {3},
pages = {100737},
doi = {10.1016/j.mcpro.2024.100737}
}
EUVIMED